Patent · US Active

Radiotherapies and uses thereof

US12179037B2 · kind B2 · utility

0Cited by
9References
105Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 2019
Grant dateDec 31, 2024
Priority date
Expiry dateNov 22, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are methods for sequential radiotherapies, such as XRT. In some embodiments, a higher dosage of an XRT may first be administered to a subject, optionally in combination with an immunotherapy, and subsequently a lower dosage XRT is administered to the subject to treat a cancer. Separating the dosage and intensity of the radiotherapies can be used to achieve improved therapeutic responses, such as improved anti-cancer responses, survival times, and/or abscopal effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.